(Q57008129)

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Human Borrelia miyamotoi infection in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

The expanding Lyme Borrelia complex—clinical significance of genomic species?

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Whole genome sequence of an unusual Borrelia burgdorferi sensu lato isolate

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Multilocus sequence analysis of atypical Borrelia burgdorferi sensu lato isolates--description of Borrelia californiensis sp. nov., and genomospecies 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Genetic diversity of Borrelia burgdorferi and detection of B. bissettii-like DNA in serum of north-coastal California residents

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

The burgeoning molecular genetics of the Lyme disease spirochaete

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

The plasmids of Borrelia burgdorferi: essential genetic elements of a pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Salivating for knowledge: potential pharmacological agents in tick saliva

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Life cycle of Borrelia burgdorferi sensu lato and transmission to humans

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Ticks and tickborne bacterial diseases in humans: an emerging infectious threat

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Induction of an outer surface protein on Borrelia burgdorferi during tick feeding

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Risk of infection with Borrelia burgdorferi sensu lato for a host in relation to the duration of nymphal Ixodes ricinus feeding and the method of tick removal.

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Interaction between Borrelia burgdorferi and immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Activation of gamma delta T cells by Borrelia burgdorferi is indirect via a TLR- and caspase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release.

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Antialarmin effect of tick saliva during the transmission of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Microarray analyses of inflammation response of human dermal fibroblasts to different strains of Borrelia burgdorferi sensu stricto

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Chemokines and Toll-like receptors in Lyme disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Illuminating the roles of the Borrelia burgdorferi adhesins

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

The Lyme disease agent exploits a tick protein to infect the mammalian host

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

The tick salivary protein Salp15 inhibits the killing of serum-sensitive Borrelia burgdorferi sensu lato isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

An immune evasion mechanism for spirochetal persistence in Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

'Nothing is permanent but change'- antigenic variation in persistent bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Transovarial transmission of Borrelia burgdorferi in Ixodes dammini (Acari:Ixodidae)

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Stage-associated risk of transmission of the Lyme disease spirochete by European Ixodes ticks

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Clinical manifestations and diagnosis of lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Skin manifestations of lyme borreliosis: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

An epidemiologic study of Lyme disease in southern Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Stages and syndromes of neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Borrelia burgdorferi infection and cutaneous Lyme disease, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

[Ocular manifestations of Lyme disease]

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

[Dermatological aspects of Lyme borreliosis]

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

When is the best time to order a Western blot and how should it be interpreted?

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

[Seroprevalence of Lyme Borreliosis and tick-borne encephalitis in workers at risk, in eastern France].

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

What are the indications for lumbar puncture in patients with Lyme disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Treatment and prevention of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021

Common misconceptions about Lyme disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1773-035X%2813%2972265-2

7 January 2021